# Efficacy and Safety of Sugammadex in Renal Diseased Patients

> **NCT01785758** · PHASE4 · COMPLETED · sponsor: **Federal University of São Paulo** · enrollment: 40 (actual)

## Conditions studied

- Kidney Failure, Chronic
- Neuromuscular Blockade

## Interventions

- **DRUG:** Sugammadex (4 mg/Kg)

## Key facts

- **NCT ID:** NCT01785758
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01785758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01785758, "Efficacy and Safety of Sugammadex in Renal Diseased Patients". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT01785758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*